Novo Nordisk expands discounted Wegovy to all cash-paying US customers-March 2024-www.financetom.com

Novo Nordisk expands discounted Wegovy to all cash-paying US customers

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novo Nordisk expands discounted Wegovy to all cash-paying US customers

Mar 24, 2025 5:29 AM

March 24 (Reuters) - Novo Nordisk said on

Monday all eligible cash-paying customers in the United States

can buy its weight-loss drug Wegovy at a discounted price of

$499 per month at their local pharmacy.

Until now, the drug was only available at the discounted

price through its NovoCare Pharmacy program.

Previous page： CRH Plans to Delist From London Stock Exchange Next page： Celanese raises prices for engineered metals amid supply-chain disruptions

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

CRH Plans to Delist From London Stock Exchange

Mar 13, 2026

04:42 PM EDT, 03/13/2026 (MT Newswires) -- CRH (CRH) said late Friday it plans to delist its ordinary shares and 7% preference shares from the London Stock Exchange. Once the LSE delisting occurs, CRH's ordinary shares will be solely listed on the New York Stock Exchange, the company said. It is expected that the LSE delisting will take effect on...

Celanese raises prices for engineered metals amid supply-chain disruptions

Mar 13, 2026

March 13 (Reuters) - Celanese Corp ( CE ) said on Friday it has increased prices for a range of engineered materials products in response to various factors, including global supply-chain disruptions. ...

Applovin Insider Sold Shares Worth $18,717,610, According to a Recent SEC Filing

Mar 13, 2026

04:45 PM EDT, 03/13/2026 (MT Newswires) -- Arash Adam Foroughi, 10% Owner, Director, CEO & Chairperson, on March 12, 2026, sold 40,704 shares in Applovin ( APP ) for $18,717,610. Following the Form 4 filing with the SEC, Foroughi has control over a total of 7,724,469 Class A common shares of the company, with 2,430,414 shares held directly and 5,294,055...

Applovin Insider Sold Shares Worth $1,409,678, According to a Recent SEC Filing

Mar 13, 2026

04:44 PM EDT, 03/13/2026 (MT Newswires) -- Dmitriy Dorosh, Principal Accounting Officer, on March 13, 2026, sold 3,109 shares in Applovin ( APP ) for $1,409,678. Following the Form 4 filing with the SEC, Dorosh has control over a total of 111,515 Class A common shares of the company, with 111,515 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1751008/000200296226000003/xslF345X05/primarydocument.xml ...